People: STAAR Surgical Co (STAA.W)

Summary

Name	Age	Since	Current Position
Don Bailey	67	2005	Independent Chairman of the Board
Barry Caldwell	61	2007	President, Chief Executive Officer, Director
Deborah Andrews	54	2005	Chief Financial Officer, Vice President
Hans-Martin Blickensdoerfer	46	2010	President, Europe, Middle East, Africa, Latin America
Donald Todd	59		President, Asia Pacific
Hideo Watanabe	60	2011	President, STAAR Japan
Paul Hambrick	50	2006	Vice President - Global Operations
Philippe Subrin	48	2010	Vice President - Switzerland Operations
Samuel Gesten	50	2012	Vice President, General Counsel, Corporate Compliance Officer and Secretary
Robin Hughes	48	2012	Vice President - Research and Development, Regulatory and Quality
Donald Fagen	58	2010	Vice President - North American Sales
James Francese	48	2012	Vice President - Global Marketing
William Goodmen	57		Vice President - Global Human Resources
John Santos	56	2008	Vice President - Global Quality Assurance, Regulatory and Clinical Affairs
Craig Felberg	61	2012	Vice President - Business Development
Charles Slacik	58	2012	Director
Mark Logan	73	2010	Independent Director
Richard Meier	53	2009	Independent Director
John Moore	68	2008	Independent Director

» Insider Trading

Biographies

Name	Description
Don Bailey	Mr. Don Bailey serves as Independent Chairman of the Board of STAAR Surgical Company. He has served as a Director and Chairman since April 2005, and serves as the chairman of the Nominating and Governance Committee of the Board of Directors. Since November 26, 2007, Mr. Bailey has served as President, Chief Executive Officer and a director of Questcor Pharmaceuticals, Inc., having served as its interim President from May 2007 and as a director since May 2006. In addition, he served as Chairman of the Board of Comarco, Inc., a provider of wireless test products for the wireless industry and a maker of emergency call box systems and mobile power products for handheld devices, from 1998 until August 31, 2007. He also served from June 1990 to April 2000 as President of Comarco, Inc. and as its Chief Executive Officer from January 1991 to April 2000. Mr. Bailey earned his Bachelor of Science degree in Mechanical Engineering from Drexel University in 1968, his Master of Science degree in Operations Research from the University of Southern California in 1971 and his Master of Business Administration degree from Pepperdine University in 1986.
Barry Caldwell	Mr. Barry Caldwell is President, Chief Executive Officer, Director of STAAR Surgical Company. He was elected to STAAR’s Board of Directors at its 2007 Annual Meeting, and he has served as STAAR’s President and Chief Executive Officer since November 27, 2007. Mr. Caldwell previously served as President, Chief Executive Officer and director of Iridex Corporation, a worldwide provider of therapeutic laser systems and delivery devices used to treat eye diseases and skin conditions, from 2005 through 2007. From 1979 to 2002, Mr. Caldwell served in various capacities with Alcon Laboratories, Inc., a leading developer, manufacturer and marketer of ophthalmology products. His executive positions included Vice President and General Manager of Alcon’s U.S. Surgical Division and Vice President of Alcon Canada. From 2002 to 2005, Mr. Caldwell served on the Boards of Directors of Laser Diagnostic Technologies (until its sale in 2004), A.R.C. Laser, Inc. and Tekia, Inc. In addition, he has served on the Boards of Directors for three ophthalmic industry groups, AdvaMed, NAEVR and EyeRx Coalition. He is also a former member of the Kentucky State Legislature where he served three consecutive terms in the State’s House of Representatives. Mr. Caldwell has a Bachelor of Arts degree in Political Science and English from Georgetown College and a Juris Doctorate from the Northern Kentucky University Chase College of Law.
Deborah Andrews	Ms. Deborah Andrews serves as Chief Financial Officer, Vice President of STAAR Surgical Company. Ms. Andrews has served as Chief Financial Officer since August 2005 and as Vice President since April 2005. She has been employed by STAAR since 1995, serving as Principal Financial Officer from April 2005 to August 2005, Global Controller from 2001 to 2005, Vice President, Finance, of STAAR Surgical AG (Switzerland) from 1999 to 2001, and Assistant Controller from 1995 to 1999. She previously served as an internal auditor for Bourns, Inc., a maker of electronic components, from 1994 to 1995, and an auditor for KPMG Peat Marwick from 1991 to 1994. Ms. Andrews earned her Bachelor of Science degree in Accounting from California State University, San Bernardino.
Hans-Martin Blickensdoerfer	Mr. Hans-Martin Blickensdoerfer is President, Europe, Middle East, Africa, Latin America of STAAR Surgical Company. Mr. Blickensdoerfer, who joined STAAR in January 2005, has over 15 years experience in the ophthalmic device industry. Prior to joining STAAR, Mr. Blickensdoerfer served from January 2003 through December 2004 as Vice President of Sales and Marketing for Milvella Ltd., an Australia-based medical device maker, where his duties included both regional and worldwide business planning, product launches and management of European clinical studies. He worked from 2000 through 2002 for Novartis-CIBA Vision as the Commercial Director for Europe, the Middle East and Africa. Between 1997 and early 2000 he worked for the Surgical Division of Bausch & Lomb, Inc. as its Area Sales Manager for Central and Eastern Europe. Prior to that time he worked in sales and product management positions in the Surgical Division of Chiron Vision and at Chiron Adatomed GmbH. Mr. Blickensdoerfer received his diploma in Marketing and International Management from the University of Mannheim in Germany. He is based in the company's Nidau, Switzerland facility.
Donald Todd	Mr. Donald Todd serves as President, Asia Pacific of STAAR Surgical Company. Mr. Todd joined STAAR on August 16, 2010. From 2008 to 2010 he served as Global Vice President for VNUS Medical Technologies, a division of Covidien Company, specializing in Radio Frequency treatment for venous insufficiency. Prior to that position, he worked for three years from 2005 to 2008 as Senior Vice President, Marketing for Iridex Corp., an ophthalmic and aesthetic laser company. His background includes Executive Vice President and senior management positions in cardiovascular and ophthalmic medical device companies such as CooperVision/Alcon, Iolab, Sorin Group, Venetec International and Terumo Medical. Mr. Todd earned a Bachelor of Arts degree in Business Administration from Colorado State University.
Hideo Watanabe	Mr. Hideo Watanabe serves as President, STAAR Japan of STAAR Surgical Company since April 2011. He has 20 years of experience within the medical devices sector with experience in managing multi-cultural business organizations. Fluent in both English and Japanese, Mr. Watanabe has broad experience working with both international and domestic companies. From January 2011 to April, 2011 Mr. Watanabe served as a sales consultant to KAVO Dental Systems, Japan. From 2007 to 2009 Mr. Watanabe held the position of President and Managing Director for Elekta K.K. in Tokyo. Prior to this he held management positions in a number of companies in Japan including in 2007 Mr. Watanabe served as General Manager, Sales for the Japanese affiliate of Volcano, Inc., AZE Limited and Philips Medical Systems. He also spent 16 year with the GE Group holding positions of increasing responsibility within Sales and Marketing. His last position with GE was as Deputy General Manager for GE Marquette Medical Systems Japan. Mr. Watanabe obtained his BS degree in Mechanical Engineering and Fluid Dynamics from Meiji University, Tokyo, Japan.
Paul Hambrick	Mr. Paul Hambrick serves as Vice President - Global Operations of STAAR Surgical Company since February 2006. Mr. Hambrick has served as the company's Vice President of Operations since February of 2006. He has over 30 years of operations experience in the medical industry and 23 years’ experience in the manufacturing of cataract surgical products. From late 2005 through February 2006 he served as Divisional Manager of Engineering at Bio-Rad Laboratories, a manufacturer of products for life science research and clinical diagnostics. From 2001 through 2005 Mr. Hambrick served as General Manager and Vice President of Operations at MAS, a Fisher Scientific Company, managing the production of in-vitro diagnostic products. From 1998 to 2001 he was Director of Manufacturing at Biosense Webster, a Johnson & Johnson company, where he oversaw production of electrophysiology catheters. Prior to joining Biosense Webster, Mr. Hambrick was Director of Manufacturing at Chiron Vision with various product line responsibilities including manufacturing of intraocular lenses, phacoemulsification systems and keratome blades. Mr. Hambrick earned his Bachelor of Science Degree in Business Administration from the University of La Verne in La Verne, California.
Philippe Subrin	Mr. Philippe Subrin is Vice President - Switzerland Operations of STAAR Surgical Company. Mr. Subrin joined STAAR Surgical AG, the company's subsidiary in Nidau, Switzerland on January 8, 2002 and is responsible for Swiss Operations. Previously, he has held senior manufacturing positions at Bausch & Lomb and Domilens in France. In 1995, he was Manufacturing Manager at Bausch & Lomb in Lyons, France and responsible for the company’s Intraocular Lens (IOL) manufacturing line. While working at Bausch & Lomb in Florida, Philippe focused on process improvements and development for their 3-piece Silicone IOL. Mr. Subrin earned a degree in Optometry from the University of Morez in France and also a degree in Engineering and Operational Management from the University of Lyon, Lyon, France.
Samuel Gesten	Mr. Samuel J. Gesten has been appointed as Vice President, General Counsel, Corporate Compliance Officer and Secretary of STAAR Surgical Co., effective April 5, 2012. Mr. Gesten joins STAAR from Allergan, where he worked for over two years, most recently serving as its Executive Vice President, General Counsel and Assistant Secretary and as a member of the Executive Committee. Prior to that, he spent 11 years at Thermo Fisher Scientific in a variety of positions, including General Counsel and Assistant Secretary of the Laboratory Products Group and Vice President, Deputy General Counsel. Mr. Gesten was a contributor to the success of two global health care companies. Allergan, with its focus on innovative pharmaceuticals, biologics, medical devices and over-the-counter products. Thermo Fisher Scientific (TMO). Prior to his work at TMO, Mr. Gesten spent 11 years practicing law. He has a B.A. degree in economics from Brandeis University and a J.D. from Boston University.
Robin Hughes	Mr. Robin Hughes has been appointed as Vice President - Research and Development, Regulatory and Quality of STAAR Surgical Co., effective 04 September 2012. Mr. Hughes has over 20 years of experience in the ophthalmic industry including the past five as V.P. of Global Marketing at STAAR. His scientific background includes qualifications in medical microbiology from The Royal London Hospital, and in human physiology and cell biology from the University of Westminster. He also earned a Master of Business Administration from Henley Management College.
Donald Fagen	Mr. Donald Fagen is Vice President - North American Sales of STAAR Surgical Company. Mr. Fagen joined STAAR on January 13, 2010. Prior to joining STAAR Mr. Fagen had 21 years of experience in sales and marketing of ophthalmic devices, most recently serving as a consultant to Abbot Medical Optics from January 2009 until December 2009. From March 2008 through January 2009, Mr. Fagen served as Vice President of Sales and Marketing for Syneron Medical Ltd, a maker of lasers used in aesthetic medical procedures. Mr. Fagen served as Vice President of Sales and Marketing for VISX Incorporated, a maker of lasers used in customized LASIK refractive surgery, from January 2001 through May 2005, when VISX was acquired by Advanced Medical Optics Inc. (now Abbott Medical Optics.). Following the acquisition, he continued to serve as Vice President of Sales and Marketing for VISX as a unit of Advanced Medical Optics through March of 2008. Among Mr. Fagen’s earlier experience, he served as National Sales Manager for Cooper Vision and for Alcon after its acquisition of Cooper Vision, where his employment extended from 1983 through 1997. He also served as a lieutenant in the U.S. Marine Corps from 1976 to 1980. Mr. Fagen earned his Bachelor of Science degree in Education and History from Texas State University in 1976. He has received additional training at the Graduate School of Business at Stanford and Columbia University and the Graduate School of Management at UCLA.
James Francese	Mr. James Francese has been appointed as Vice President - Global Marketing of STAAR Surgical Co., effective 04 September 2012. Mr. Francese has 22 years of experience in ophthalmology, including 14 years marketing surgical products with Abbott Medical Optics, formerly Advanced Medical Optics (AMO) and Allergan. During his time at AMO, Mr. Francese held several positions of executive level responsibilities, including Head of Marketing, Americas for all surgical, refractive and corneal products, Head of Global Corneal Marketing responsible for all consumer products, and V.P. of Asia Pacific Region where he had full P&L responsibility for cataract and refractive during his tenure. He received his Bachelor of Science degree from Cornell University, Master of Science degree from the University of Washington and Master of Business Administration degree from the University of Southern California.
William Goodmen	Mr. William Goodmen serves as Vice President - Global Human Resources of STAAR Surgical Company. Mr. Goodmen joined STAAR on August 16, 2010. Prior to joining STAAR, he served as Vice President, Business Development for Neovia Integrated Insurance Services, a healthcare brokerage firm, from 2009 to 2010. His prior experience also includes seven years at THQ, Inc., a developer of interactive entertainment software where he served as Executive Vice President of Human Resources and Administration from 2002 to 2009. During this time period, he was responsible for all Human Resources and general administrative functions worldwide. This company grew from $400 million to $1.2 billion in sales and 600 to 2,500 employees. Additional experience includes senior management positions in Human Resources at Liberty Livewire and in executive search with Spencer Stuart. He began his human resources career at Atlantic Richfield Co., a Fortune 500 energy company, where he spent 18 years. Mr. Goodmen earned a Bachelor of Arts degree from Colgate University and a Master of Science degree from Syracuse University.
John Santos	Mr. John Santos serves as Vice President - Global Quality Assurance, Regulatory and Clinical Affairs of STAAR Surgical Company since November 2008. Mr. Santos, who joined STAAR in October 1992, has over 16 years’ experience in the ophthalmic device industry. Prior to his current post he was STAAR’s Vice President of Corporate Planning and Development from August 2001 until November 2008. Prior to that he served as Vice President Finance and Chief Financial Officer from May 2000 to August 2001, as Vice President Controller from March 1999 to May 2000, and as Controller from October 1992 to March 1999. Prior to his employment at STAAR he worked for Calmar, Inc. in accounting and finance positions. He received his Bachelor of Science degree in Business Administration from California State University Fullerton and his Master’s degree in Business Administration from Pepperdine University.
Craig Felberg	Mr. Craig Felberg has been appointed as Vice President - Business Development of STAAR Surgical Co., effective 04 September 2012. Mr. Felberg will lead a Business Development team consisting of STAAR's General Counsel Sam Gesten, Robin Hughes and CEO Barry Caldwell. He has 30 years of experience in the ophthalmic surgical business including the past five years as V.P. of Research and Development at STAAR. He received his Bachelor of Arts in Management from the University of Redlands and Master of Business Administration from Pepperdine University.
Charles Slacik	Mr. Charles P. Slacik, CPA, has been appointed as Director of Staar Surgical Co., effective September 7, 2012. Prior to joining Beckman Coulter, Mr. Slacik served as Executive Vice President and Chief Financial Officer of Watson Pharmaceuticals Inc. from 2003 to 2006. He was responsible for all financial operations of Watson, a integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, brand and biologic pharmaceutical products. From 1999 to 2003 he served as Senior Vice President and Chief Financial Officer of CR Bard Inc., a provider of medical, surgical, diagnostic, and patient care devices. Previously, Mr. Slacik held positions of growing responsibility for numerous divisions of Wyeth (formerly American Home Products Corporation) starting in 1982 in various financial and operating positions including Corporate Controller, Executive Vice President of Whitehall-Robins Consumer Products, Sherwood-Davis & Geck Medical Device Group, and American Cyanamid Agricultural Products Group. In his last Wyeth role, he served as Chief Operating Officer of the Solgar Division, one of Wyeth's acquired companies. Early in his career, he earned his Certified Public Accountant (CPA) license and worked as a senior auditor for Arthur Andersen & Co. He is a member of the Orange County Chapter of Financial Executives International and the Connecticut Society of CPAs. Mr. Slacik received his B.S. in Accounting and Finance from the University of Connecticut.
Mark Logan	Mr. Mark B. Logan is Independent Director of STAAR Surgical Company. Mr. Logan has 35 years of executive level experience in the health care products industry. He served as Chairman and Chief Executive Officer of VISX, Inc. from 1994 to 2001. VISX was subsequently acquired by Advanced Medical Optics (now a part of Abbott Laboratories). Prior to joining VISX, Mr. Logan served as Chairman and CEO of Insmed Pharmaceuticals, Inc., and before that he was a principal at McManus Associates (a healthcare research and management firm), with clients including Merck, Bristol Myers Squibb and American Diabetes Association. Before that, he spent four years as Executive Vice President and Chief Operating Officer and board member at Bausch & Lomb. His prior experience includes senior executive positions at Becton, Dickinson & Company and Wyeth, Inc. Mr. Logan is Chairman of the Board of VIVUS, Inc., a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. Mr. Logan also serves on the board of the University of Virginia Heart & Vascular Center, serves as a director of Public Policy Virginia, Inc. and serves as a trustee of the Southern Environmental Law Center. Mr. Logan earned a Bachelor of Arts degree in Biology from Hiram College. He was a Woodrow Wilson Fellow at New York University and has a PMD from Harvard University.
Richard Meier	Mr. Richard A. (Randy) Meier is Independent Director of STAAR Surgical Company. He has served as the Chairman of its Audit Committee since March 2010. Mr. Meier served as Executive Vice President and Chief Financial Officer of Teleflex Incorporated, a global provider of medical devices, from January 2010 to March 2012. Prior to that position he was President and Chief Operating Officer of Advanced Medical Optics from February 2007 through April 2009, when it was acquired by Abbott Laboratories. From April 2006 to February 2007, Mr. Meier was Advanced Medical Optics’ Executive Vice President, Operations, President, Global Eye Care, and Chief Financial Officer. From February 2004 to April 2006, he was Advanced Medical Optics’ Executive Vice President of Operations and Finance and Chief Financial Officer, and from April 2002 to February 2004, Mr. Meier was Corporate Vice President and Chief Financial Officer. Prior to joining Advanced Medical Optics, Mr. Meier was the Executive Vice President and Chief Financial Officer of Valeant Pharmaceuticals, Inc., from October 1999, and Senior Vice President & Treasurer from May 1998 to October 1999. Before joining Valeant, Mr. Meier was an executive with the investment banking firm of Schroder & Co. Inc. in New York, from 1996. Prior to Mr. Meier’s experience at Schroder & Co., he held various financial and banking positions at Salomon Smith Barney, Manufacturers Hanover Corporation, Australian Capital Equity, and Greyhound Lines, Inc.Mr. Meier is a graduate of Princeton University with a Major in Economics.
John Moore	Mr. John C. Moore serves Independent Director of STAAR Surgical Company since January 2008. Mr. Moore has more than 25 years of executive experience at ophthalmic medical device companies, where he managed R&D, operations, marketing, sales, business development, service, and finance teams. Between April 2005 and January 2007, Mr. Moore served as CEO of Notal Vision, an Israel-based company that developed comprehensive diagnostic solutions for the early detection and monitoring of age-related macular degeneration (AMD). Mr. Moore served as the President and CEO of Laser Diagnostic Technologies, a manufacturer of diagnostic laser scanning ophthalmoscopes used for the early detection of glaucoma, from 2000 until it was acquired by Carl Zeiss Meditec, Inc. in 2004. Before this, Mr. Moore was a vice president at Alcon Laboratories where he was responsible for pursuing and executing strategic acquisitions and partnerships to broaden that company's product portfolio. Mr. Moore also spent more than 10 years at Carl Zeiss, Inc., a multinational company with primary businesses in optics, medical, scientific and semiconductor products. Mr. Moore received his Bachelor of Science degree in General Science from University of Rochester.

Basic Compensation

Name	Fiscal Year Total
Don Bailey	--
Barry Caldwell	1,069,640
Deborah Andrews	524,674
Hans-Martin Blickensdoerfer	581,545
Donald Todd	--
Hideo Watanabe	--
Paul Hambrick	335,081
Philippe Subrin	493,984
Samuel Gesten	--
Robin Hughes	518,157
Donald Fagen	--
James Francese	--
William Goodmen	--
John Santos	167,043
Craig Felberg	--
Charles Slacik	--
Mark Logan	--
Richard Meier	--
John Moore	--

As Of 29 Dec 2011

Options Compensation

Name	Options	Value
Don Bailey	0	0
Barry Caldwell	0	0
Deborah Andrews	131,001	373,900
Hans-Martin Blickensdoerfer	0	0
Donald Todd	0	0
Hideo Watanabe	0	0
Paul Hambrick	0	0
Philippe Subrin	0	0
Samuel Gesten	0	0
Robin Hughes	0	0
Donald Fagen	0	0
James Francese	0	0
William Goodmen	0	0
John Santos	103,000	0
Craig Felberg	0	0
Charles Slacik	0	0
Mark Logan	0	0
Richard Meier	0	0
John Moore	0	0

Insider Trading

Name	Shares Traded	Price
SLACIK CHARLES P	2,000	$9.19
LOGAN MARK B	10,800	$0.00
MEIER RICHARD A	10,800	$0.00
MOORE JOHN C	10,800	$0.00
SLACIK CHARLES P	5,400	$0.00
ANDREWS DEBORAH J	5,000	$8.96
GESTEN SAMUEL J	1,697	$5.62
HUGHES ROBIN	7,500	$0.00
FRANCESE JAMES E	7,500	$0.00
SUBRIN PHILIPPE	7,500	$0.00
GESTEN SAMUEL J	7,500	$0.00
BLICKENSDOERFER HANS MARTIN	7,500	$0.00
ANDREWS DEBORAH J	7,500	$0.00
CALDWELL BARRY G	15,000	$0.00
MOORE JOHN C	5,000	$5.46
ANDREWS DEBORAH J	3,000	$3.60
LOGAN MARK B	600	$5.00
BROADWOOD PARTNERS L P	2,618	$5.00
CALDWELL BARRY G	5,000	$5.04
LOGAN MARK B	3,000	$5.27
BROADWOOD PARTNERS L P	22,572	$5.00
SLACIK CHARLES P	2,000	$0.00
GOODMEN WILLIAM WALTER	16,667	$4.69
GOODMEN WILLIAM WALTER	16,667	$6.97
MOORE JOHN C	2,500	$0.00

» Full list on Insider Trading

People: STAAR Surgical Co (STAA.W)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: